Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...
Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...
They then deployed genome sequencing to analyse the genetic effects of these structural variations on cell survival. It ...
14h
AZoLifeSciences on MSNNew CRISPR Tool Reveals Key Lymphoma GenesThis study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in lymphoma development and therapy.
Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...
On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...
KBC Group NV grew its stake in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 71.4% during the 4th quarter, Holdings Channel reports. The firm owned 2,942 shares of the company’s stock after ...
Ever-Growing USA on MSN6h
Cell Line Development Process – Challenges and Best PracticesCell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.
A Massachusetts man suffering from end-stage kidney disease has become the second living person to receive a genetically modified pig kidney transplant, marking a major milestone in the field of ...
According to climate models and research conducted by the IPCC, NASA and other scientific institutions, their frequency, intensity and duration are expected to grow in the future. Apart from the ...
UMD researchers have discovered key mechanisms in gene regulation that could improve the design of RNA-based medicines.
Equities researchers at Leerink Partnrs boosted their Q2 2025 earnings estimates for shares of Twist Bioscience in a research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results